Aristotle University Of Thessaloniki (AUTH)
Αιμοδυναμική μελέτη της πνευμονικής κυκλοφορίας στην άσκηση σε ασθενείς με πνευμονική ίνωση
Abstract
dc:descriptionPulmonary hypertension (PH) can occur as a complication of interstitial fibrosing lung disease (IFLD), negatively affecting patients’ functional capacity and prognosis. A thorough cardiopulmonary evaluation including right heart catheterization (RHC) is therefore needed, to properly diagnose and differentiate between pre- and post-capillary (preC and postC, respectively) PH. Moreover, the implementation of an exercise protocol during RHC is gaining ground in the field of IFLD and of other pulmonary and cardiac diseases, potentially promising the prompt detection of pulmonary vasculopathy. The criterion of abnormal elevation of mean pulmonary artery pressure (mPAP) above 30 mmHg during exercise, with respect to abnormal elevation of cardiac output (mPAP–CO ratio ⩾3 mmHg·min·L−1) is increasingly being used for the definition of exercise pulmonary hypertension (ePH). Furthermore, criteria to define abnormal pulmonary artery wedge pressure (PAWP) elevation during exercise are currently being established, contributing to an integrated understanding of exercise vascular responses. The clinical significance of ePH in pulmonary and cardiac diseases has been documented, representing a risk factor for decreased exercise capacity and survival, progression to PH and overall clinical worsening.Driven by these trends, we conducted a prospective study aiming at: (a) assessing the prevalence of PH and ePH in a cohort of 40 functionally limited patients with IFLD and (b) examining the correlations between invasively and non-invasively measured exercise variables among hemodynamic groups. Among the few existing studies assessing the pulmonary vascular responses to exercise in IFLD patients, our study is the first to also investigate the prevalence of postC etiology of PH and ePH, using resting and exercise RHC, thus providing distinct phenotypes of exercise limitation in IFLD.This prospective study was approved by the ethics board of the Aristotle University of Thessaloniki, Greece, and informed consent was obtained by all subjects. A consecutive population of 40 Caucasian patients presenting with pulmonary fibrosis, either idiopathic or secondary to connective tissue disease (CTD) were evaluated at the Pulmonary Hypertension Outpatient Clinic of the Department of Respiratory Failure, in the General Hospital of Thessaloniki, “G.Papanikolaou”. Diagnosis of the underlying etiology of the fibrotic lung disease was established at the Interstitial Lung Disease Outpatient Clinic of the University Respiratory Department, according to international guidelines. Patients underwent cardiopulmonary evaluation, including clinical examination, lung function tests, 6-minute walking test (6MWT), heart ultrasonography, and cardiopulmonary exercise test (CPET), unless contraindicated, during their initial visit. A second visit was scheduled one to two weeks after the first, to perform RHC. Pulmonary vascular compliance (PVC) was calculated by the ratio of stroke volume (SV) to (sPAP-dPAP). The ratio of PAWP to CO (ΔPAWP/ΔCO) was calculated as follows: 9. ΔPAWP/ΔCO ≤2 mmHg/L per minute determined a preC etiology, while ΔPAWP/ΔCO >2 mmHg/L per minute a postC etiology.Forty (N=40) IFLD patients were evaluated. Mean age was 68±11 years, and pulmonary restriction was variable, from mild to moderate. Patients were equally distributed across NYHA classes II, III and IV. Idiopathic pulmonary fibrosis (IPF) was diagnosed in 75% of the patients (n=30), with lung fibrosis secondary to CTDs among the remaining 25% (systemic sclerosis, n=6, rheumatoid arthritis, n=3, systemic lupus erythematosus, n=1). Radiologic severity of fibrosis was mostly moderate (50%, n=20), with mild fibrosis documented for 35% and severe for 15%. Initial hemodynamic evaluation allocated patients into four groups: (a) normal group (n=4, 10%), presenting normal hemodynamics at rest and exercise, (b) ePH group (n=11, 27.5%), presenting normal resting hemodynamics and ePH, (c) preC-PH group (n=15, 37.5%), presenting preC-PH at rest, and (d) postC-PH group (n=10, 25%); presenting post-C PH at rest. The postC-PH group did not undergo further exercise hemodynamic evaluation. Secondary hemodynamic evaluation involved detection of abnormal PAWP increase at peak exercise in relation to CO (ΔPAWP/ΔCO> 2mm Hg/L per minute), thus dividing the ePH and preC-PH groups into the following subgroups: (i) preC-ePH group (n=7), presenting preC etiology of ePH, (ii) postC-ePH group (n=4), presenting postC etiology of ePH, (iii) preC-PH-PAWP (n=9), presenting preC etiology of PH, (iv) preC-PH+PAWP (n=6), presenting postC etiology of PH. A cut-off value of 24mmHg for peak PAWP differentiating preC and postC etiology was driven by the implementation of the main stated criterion. In conclusion, the current study performed pulmonary hemodynamic measurements at rest and at exercise in a stable population of functionally limited IFLD patients with various degrees of respiratory restriction, identifying a high prevalence of ePH (27.5%) and PH (preC=37.5%, postC=25%), suggesting that RHC should be offered more frequently in functionally limited patients. The ePH phenotype displayed lower resting CO and CI values, indicating the contribution of cardiopulmonary function in exercise limitation. Furthermore, the poor correlation in IPF between PH and lung function markers has been largely known and aligns with our results, where no such association was observed. The sole exception were diffusion capacity markers that presented a strong association to pulmonary vasculopathy; a finding also consistent with existing literature. Finally, the use of the ΔPAWP/ΔCO>2 criterion further uncovered postcapillary etiology of PH and ePH, highlighting the complexity of hemodynamics in IFLD. However, further studies with a more homogeneous patient population are needed to confirm these findings.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Panagiotidou, Evangelia
- Παναγιωτίδου, Ευαγγελία
Subjects
dc:subject × 14- Πνευμονική ίνωση
- Πνευμονική υπέρταση
- Δεξιός καρδιακός καθετηριασμός
- Άσκηση
- Interstitial pulmonary fibrosis
- Pulmonary hypertension
- right heart catheterization
- Exercise
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Πνευμονολογία και Αναπνευστικές παθήσεις
- Clinical Medicine
- Medical and Health Sciences
- Pulmonary and Respiratory Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52400